Advertisement

Topics

Daiichi Pure Chemicals Company Limited Company Profile

20:56 EST 19th November 2017 | BioPortfolio

Drug Discovery

Location

3-13-5 Nihombashi Chuo-ku
Tokyo
Tokyo
103
Japan

Contact

Fax: 81 3 3272 0671


News Articles [894 Associated News Articles listed on BioPortfolio]

FDA Grants Breakthrough Therapy Designation to Daiichi Sankyo’s DS-8201 for HER2-Positive Metastatic Breast Cancer

Tokyo, Japan, Basking Ridge, NJ, and Munich, Germany – (August 29, 2017) – Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the U.S. Food and Drug Administration (F...

Daiichi Sankyo & Glycotope Enter Option Agreement for Antibody Drug Conjugate Strategic Collaboration and Licensing

TOKYO and BASKING RIDGE, N.J., and BERLIN, Oct. 30, 2017 /PRNewswire/ — Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and Glycotope GmbH (hereafter, Glycotope) have signed an optio...

Global Fine Chemicals Market 2017: By End-Use Industry & Geography -Forecast by 2022

Fine Chemicals Market : Executive Summary Fine chemicals can be classified and defined as complex, single, pure chemical substances, which are produced in limited quantities according to exacting spec...

Daiichi Sankyo inks Glycotope ADC deal

Daiichi Sankyo Company has signed an option agreement to develop Glycotopeâs antibody drug conjugate (ADC) to target various cancers including ovarian, lung and breast tumours.

Daiichi Sankyo and MD Anderson Collaborate to Accelerate Development of Acute Myeloid Leukemia Therapies

HOUSTON and TOKYO and BASKING RIDGE, N.J., Sept. 14, 2017 /PRNewswire/ — The University of Texas MD Anderson Cancer Center and Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today a...

PURE Bioscience Announces Superior In-Plant Poultry Parts Test Results With PURE Control Antimicrobial

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (

Daiichi Sankyo, Boston Pharmaceuticals sign deal for selective RET inhibitor for solid tumors

Daiichi Sankyo and Boston Pharmaceuticals have entered into a worldwide licensing agreement for Daiichi Sankyo's novel RET inhibitor, DS-5010.

Daiichi Sankyo announces support from Japan AMRD's CiCLE programme for genetic vaccine platform

Daiichi Sankyo, Company Limited announced that its development of the genetic vaccine platform utilizing in─house developed new nucleic acid delivery technology has been adopted for support under th...

PubMed Articles [586 Associated PubMed Articles listed on BioPortfolio]

Harnessing the periplasm of bacteria to develop biocatalyst for biosynthesis of highly pure chemicals.

Although biocatalytic transformation has shown great promise in chemical synthesis, there remain significant challenges in controlling high selectivity without the formation of undesirable byproducts....

A Method for Identifying Prevalent Chemical Combinations in the U.S. Population.

Through the food and water they ingest, the air they breathe, and the consumer products with which they interact at home and at work, humans are exposed to tens of thousands of chemicals, many of whic...

Hyperspectral depth-profiling with deep Raman spectroscopy for detecting chemicals in building materials.

Toxic chemicals inside building materials have long-term harmful effects on human bodies. To prevent secondary damage caused by the evaporation of latent chemicals, it is necessary to detect the chemi...

Editorial: In Good Company.

Sharing is Caring: The Case for Company-Level Collaboration in Pharmacoeconomic Modelling.

Clinical Trials [402 Associated Clinical Trials listed on BioPortfolio]

Pure Red Cell Aplasia in Patients With Chronic Kidney Disease and in Use of Epoetin Alfa

The purpose of this study is to determine occurrence of pure red cell aplasia in a group of participants with chronic renal insufficiency and with resistance criteria to epoetin alfa treat...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Olmesartan Medoxomil Tablets 40 mg and Benicar® 40 mg Tablets of Daiichi Sankyo Inc., USA. Dosing periods of studies were ...

Comparative Study of Loxoprofen Sodium Transdermal Patch and Loxonin® Tablets for the Treatment of Acute Trauma

This study evaluates the non-inferiority of the new transdermal patch dosage form containing loxoprofen sodium (100 mg - Daiichi-Sankyo) in comparison with oral Loxonin® (60 mg tablet - D...

A Study to Observe Patients Who Have Developed a More Severe Form of Anemia (Pure Red Cell Aplasia) Which is Associated With the Erythropoietin Treatment for Their Original Anemia

The purpose of this study is to investigate a possible relationship between antibodies to recombinant erythropoietin and the clinical course of Pure Red Cell Anemia (PRCA) in patients curr...

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...

Companies [2166 Associated Companies listed on BioPortfolio]

Daiichi Pure Chemicals Company Limited

Drug Discovery

Wako Chemicals USA, Inc

Wako Chemicals USA, Inc. is a wholly owned subsidiary of Wako Pure Chemical Industries, Ltd. of Japan. Wako Pure Chemicals Industries, Ltd., worldly renowned for its high purity chemicals, established...

Pure Via

Pure Via® is an all-natural, zero-calorie sweetener this is made from Rebaudioside A (Reb A), the sweetest, best-tasting part of the stevia leaf. Reb A is generally recognized ...

Daiichi Sankyo Company, Limited

Daiichi Sankyo Company, Limited, established in 2005 after the joint share transfer of two leading century-old Japanese pharmaceutical companies, is continuously generating innovative drugs that e...

DAIICHI SANKYO EUROPE GmbH and SHARE

DAIICHI SANKYO is a global pharmaceutical company that focuses on researching and marketing innovative medications. The company was created in 2005 through the merger of two traditional Japanese e...

More Information about "Daiichi Pure Chemicals Company Limited" on BioPortfolio

We have published hundreds of Daiichi Pure Chemicals Company Limited news stories on BioPortfolio along with dozens of Daiichi Pure Chemicals Company Limited Clinical Trials and PubMed Articles about Daiichi Pure Chemicals Company Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Daiichi Pure Chemicals Company Limited Companies in our database. You can also find out about relevant Daiichi Pure Chemicals Company Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record